Fischer Laurent — SEC insider filings

SEC reporting owner CIK 1379344. 37 insider filings on record with FilingPulse; latest filed 2026-10-26.

Transaction summary — filings shown

Covers all 37 filings on record, filed 2020-08-19 to 2026-10-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Adverum Biotechnologies, Inc. (ADVM)CEO, PRESIDENT AND DIRECTOR, Director208 legs · 204,991 sh · $925,2933 legs · 91,447 sh · $94,42644
Mirum Pharmaceuticals, Inc. (MIRM)Director7——11
CTI BIOPHARMA CORP (CTIC)Director4——10
AtaiBeckley Inc. (ATAI)Director2——4
ATAI Life Sciences N.V. (ATAI)Director2——2
Lycia Therapeutics, Inc. (LYCA)Director2——2

Insider filings — Fischer Laurent

FiledFormIssuerReported transactionsSource
2026-10-264Lycia Therapeutics, Inc. (LYCA)Grant/award (A): 13,307 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-10-223Lycia Therapeutics, Inc. (LYCA)Holdings only — no transactions reportedEDGAR
2026-09-114AtaiBeckley Inc. (ATAI)Disposition to issuer (D): 206,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative)EDGAR
2026-06-174Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 3,772 (derivative) @ $0 · Grant/award (A): 1,980 (derivative) @ $0EDGAR
2026-06-084AtaiBeckley Inc. (ATAI)Grant/award (A): 121,968 (derivative) @ $0EDGAR
2026-06-024Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 3,977 · Option exercise (M): 3,977 (derivative) @ $0EDGAR
2025-12-104Adverum Biotechnologies, Inc. (ADVM)Option exercise (M): 150,000 @ $4.20 · Code (U): 351,513 · Code (U): 25,000 · Grant/award (A): 500,000 @ $0 · Code (U): 522,666 · Disposition to issuer (D): 93,000 (derivative) · +10 moreEDGAR
2025-12-084Adverum Biotechnologies, Inc. (ADVM)Purchase (P): 11,085 @ $4.24 · Purchase (P): 117,614 @ $4.31EDGAR
2025-06-274ATAI Life Sciences N.V. (ATAI)Grant/award (A): 103,000 (derivative) @ $0EDGAR
2025-06-204Adverum Biotechnologies, Inc. (ADVM)Disposition to issuer (D): 120,000 (derivative) @ $0 · Grant/award (A): 120,000 (derivative) @ $0 · Disposition to issuer (D): 68,000 (derivative) @ $0 · Grant/award (A): 68,000 (derivative) @ $0 · Disposition to issuer (D): 45,499 (derivative) @ $0 · Grant/award (A): 45,499 (derivative) @ $0 · +10 moreEDGAR
2025-06-024Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 6,268 (derivative) @ $0 · Grant/award (A): 3,977 (derivative) @ $0EDGAR
2025-05-164Adverum Biotechnologies, Inc. (ADVM)Sale (S): 9,126 @ $2EDGAR
2025-02-274Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 25,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2024-08-064Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2024-06-144ATAI Life Sciences N.V. (ATAI)Grant/award (A): 206,000 (derivative) @ $0EDGAR
2024-06-074Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 8,779 (derivative) @ $0 · Grant/award (A): 5,703 (derivative) @ $0EDGAR
2024-03-124Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 315,000 (derivative) @ $0EDGAR
2024-02-144Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 1,104,200 (derivative) @ $0EDGAR
2023-06-264CTI BIOPHARMA CORP (CTIC)Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 126,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · +1 moreEDGAR
2023-06-144Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2023-04-074CTI BIOPHARMA CORP (CTIC)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2023-03-174Adverum Biotechnologies, Inc. (ADVM)Sale (S): 41,239 @ $0.78EDGAR
2023-03-034Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 930,000 (derivative) @ $0EDGAR
2022-09-214Adverum Biotechnologies, Inc. (ADVM)Sale (S): 41,082 @ $1.07EDGAR
2022-09-164Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 675,022 (derivative) @ $0 · Grant/award (A): 584,978 (derivative) @ $0EDGAR
2022-06-064Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2022-04-224Adverum Biotechnologies, Inc. (ADVM)Purchase (P): 25,000 @ $1.11EDGAR
2022-03-174Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 630,000 (derivative) @ $0EDGAR
2022-03-114CTI BIOPHARMA CORP (CTIC)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2021-12-104Adverum Biotechnologies, Inc. (ADVM)Purchase (P): 10,677 @ $1.79 · Purchase (P): 14,323 @ $1.85EDGAR
2021-08-104Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 680,000 @ $0 · Grant/award (A): 455,000 (derivative) @ $0EDGAR
2021-06-084Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2021-03-244Adverum Biotechnologies, Inc. (ADVM)Purchase (P): 10,000 @ $9.88EDGAR
2021-03-124CTI BIOPHARMA CORP (CTIC)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2021-02-184Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 680,000 (derivative) @ $0EDGAR
2021-01-194Adverum Biotechnologies, Inc. (ADVM)Purchase (P): 8,600 @ $11.53EDGAR
2020-08-194Adverum Biotechnologies, Inc. (ADVM)Purchase (P): 7,692 @ $13EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1379344 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs